Corporate Partnerships

• Advisory Council
• Corporate Education
  • China and the U.S.: Comparative Biotech Business, Law, and Regulation
  • Regulatory Management Series
  • Project Management Series for Industry Professionals
  • Life Science Briefing Series
  • Life Science Business Development Series
  • Patents and Patent Law
  • Finance and Management for Scientists
  • FDA Law and Regulatory Affairs
  • Industrial Biotech and Biofuels
  • Life Science Entrepreneur's Business Law Primer
  • Life Science Project Management Best Practices
  • Mammalian Cell Culture
  • Personalized Medicine Complimentary Panel
  • Quality Management Program
  • Next Generation Bioscience Leaders
  • Risk Management for Life Sciences
  • Science Boot Camp for Non-Scientists
• Industrial Strength Bio Seminars
• Team Masters Project: A Corporate Opportunity
• Technology Transfer

Contact Us

Location: Building 535
Phone: (909) 607-9864
Email: diana_bartlett[at symbol]kgi.edu

Personalized Medicine Complimentary Panel

Join us for this free workshop...

Today, most diagnostic and therapeutic products are designed for large numbers of patients. This one-size-fits-all approach made sense when differentiation from one person to the next was not meaningful. However, advances in genomics, vast computing power, and other technologies have enabled scientists to better define the patient groups for whom a diagnostic or therapy will be effective – and those for whom they would not. In the future, conditions and diseases will be addressed on a much more personalized scale.

Clearly, this sea change will dramatically impact all health care stakeholders – life science companies that invent and market the diagnostics and therapies, physicians who order them, health care institutions that house the interchange, patients and their families, and payors. Aligning all these stakeholders away from a ‘mass’ approach to a ‘personalized medicine’ approach is not without its challenges. How will personalized medicine unfold?

What impact will it have on companies, physicians, patients, payors, and others? Join our distinguished panel for a discussion of these issues and more.

Format: Interactive panel

Who should attend? Company representatives, physicians and other healthcare executives, consumers, payer representatives... anyone interested in learning more about the promise -- and challenges -- of personalized medicine.

Fee: Attendance is complimentary, but requires RSVP to Corporate_Education[at symbol]kgi.edu.

Instructors:

• Jim Osborne, PhD
• Ian Phillips, PhD
• Peter Heseltine, MD, FACP, FACB
• Frederick Whipple, PhD
• James W. Howatt, MD, MBA, Molina Healthcare, Inc.
• Janice Hoffmann, Restless Legs Syndrome Foundation

Date & Location: Future dates to be announced